Tafinlar
My Prescription
Payment
Select pharmacy
$17,380.63
Print or send this coupon to your phone
AlbertsonsPowered byAbout Tafinlar
Drug Details
Dabrafenib, marketed under the name Tafinlar, is a medication used to treat various cancers, including melanoma, thyroid cancer, non-small cell lung cancer, and other solid tumors with a specific BRAF mutation. It is particularly effective for cancers that have spread or cannot be surgically removed. Dabrafenib works by inhibiting the BRAF protein, which is involved in cell growth. When mutated, this protein can cause cancer to grow uncontrollably. By blocking this protein, Dabrafenib helps to slow or stop the growth of cancer cells. This medication is often used in combination with Mekinist (trametinib) to enhance its effectiveness. It is available in capsule form and can be taken orally. Potential side effects include fever, rash, and high blood sugar. Always consult healthcare professionals for advice tailored to your condition.
Price history for Tafinlar
120 Capsules, 75MG
Average retail price for Tafinlar
Average SaveHealth price for Tafinlar
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Tafinlar dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50MG | 120 Capsules | $13,488.21 | $112.40 |
| 75MG | 120 Capsules | $17,380.63 | $144.84 |
Tafinlar FAQs
Tafinlar is used to treat certain types of cancer, specifically melanoma with a BRAF V600E mutation, non-small cell lung cancer, and anaplastic thyroid cancer. It is often used in combination with another medication called Mekinist.
Yes, Tafinlar (dabrafenib) and Mekinist (trametinib) are often used in combination to treat certain types of cancer, such as melanoma with a BRAF V600E or V600K mutation. This combination can help shrink tumors by targeting specific pathways involved in cancer cell growth. However, the effectiveness can vary depending on the individual and the specific characteristics of the cancer. It is important for patients to discuss treatment options and potential outcomes with their healthcare provider.
The cost of Tafinlar can be attributed to several factors. These include the research and development expenses involved in bringing the drug to market, the costs associated with clinical trials, and the regulatory approval process. Additionally, Tafinlar is a targeted therapy used for specific cancer types, which often involves complex manufacturing processes. The pricing may also reflect the drug's effectiveness and the value it provides in treating certain conditions. Market exclusivity and patent protection can further influence the price.
Tafinlar is not classified as traditional chemotherapy. It is a targeted therapy, specifically a BRAF inhibitor, used to treat certain types of cancer by targeting specific genetic mutations within cancer cells.
While taking Tafinlar (dabrafenib) and Mekinist (trametinib), it is generally advised to avoid grapefruit and grapefruit juice. Grapefruit can interfere with the metabolism of these medications, potentially leading to increased side effects. It is always best to consult with a healthcare provider for personalized dietary recommendations while on these medications.